Treatment of CMV infection in renal transplant recipients with an abbreviated course of IV ganciclovir.

被引：0
|
作者：
Slavcheva, E
Jaffers, G
Narayanan, M
Moore, C
McCuskey, C
Carpenter, J
机构：
[1] Scott & White Mem Hosp & Clin, TAMU, Temple, TX 76508 USA
[2] Scott & White Mem Hosp & Clin, Div Nephrol, Temple, TX 76508 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：564A / 564A
页数：1
相关论文
共 50 条
  • [31] Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients
    Gish, RG
    Lau, JYN
    Brooks, L
    Fang, JWS
    Steady, SL
    Imperial, JC
    GarciaKennedy, R
    Esquivel, CO
    Keeffe, EB
    HEPATOLOGY, 1996, 23 (01) : 1 - 7
  • [32] A unique 6-week course of oral valganciclovir for CMV infection in adult renal transplant recipients.
    Smith, LD
    Aggers, P
    Shihab, F
    PHARMACOTHERAPY, 2005, 25 (03): : 475 - 475
  • [33] Pharmacokinetics of ganciclovir in pediatric renal transplant recipients
    Zhang, DL
    Lapeyraque, AL
    Popon, M
    Loirat, C
    Jacqz-Aigrain, E
    PEDIATRIC NEPHROLOGY, 2003, 18 (09) : 943 - 948
  • [34] Pharmacokinetics of ganciclovir in pediatric renal transplant recipients
    Daolun Zhang
    Anne-Laure Lapeyraque
    Michel Popon
    Chantal Loirat
    Evelyne Jacqz-Aigrain
    Pediatric Nephrology, 2003, 18 : 943 - 948
  • [35] EFFECT OF PROPHYLACTIC GANCICLOVIR ON CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS
    RONDEAU, E
    BOURGEON, B
    PERALDI, MN
    LANG, P
    BUISSON, C
    SCHULTE, KM
    WEILL, B
    SRAER, JD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (09) : 858 - 862
  • [36] EARLY TREATMENT OF CMV INFECTIONS IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS WITH FOSCARNET OR GANCICLOVIR
    BACIGALUPO, A
    VANLINT, MT
    TEDONE, E
    MORO, F
    SANNA, MA
    LONGREN, M
    TRESPI, G
    FRASSONI, F
    OCCHINI, D
    GUALANDI, F
    LAMPARELLI, T
    MARMONT, AM
    BONE MARROW TRANSPLANTATION, 1994, 13 (06) : 753 - 758
  • [37] Impact of extended CMV prophylaxis in adult renal transplant recipients at high risk for CMV infection
    Stuckey, Linda J.
    Park, Jeong M.
    Luan, Fu L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 565 - 565
  • [38] Valganciclovir provides ganciclovir plasma exposure similar to IV ganciclovir in transplant recipients
    Pescovitz, MD
    Rabkin, J
    Merion, R
    Paya, C
    Pirsch, J
    Freeman, R
    O'Grady, J
    To, Z
    Wren, K
    Buhles, W
    Brown, F
    TRANSPLANTATION, 1999, 67 (07) : S126 - S126
  • [39] The natural course of cytomegalovirus infection and disease in renal transplant recipients
    Hartmann, Anders
    Sagedal, Solbjorg
    Hjelmesaeth, Joran
    TRANSPLANTATION, 2006, 82 (02) : S15 - S17
  • [40] Outlook for transplant recipients with CMV infection improved with appropriately targeted treatment
    不详
    Drugs & Therapy Perspectives, 1998, 12 (11) : 10 - 13
12345